No Slowdown: A Midyear Look At FDA Ad Enforcement
On a single day in September last year, federal drug regulators blasted out dozens of letters accusing drugmakers of misleading consumers through expensive advertising campaigns....To view the full article, register now.
Already a subscriber? Click here to view full article